We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-4.48%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$756M
AUM Growth
+$11.9M
Cap. Flow
+$56.9M
Cap. Flow %
7.52%
Top 10 Hldgs %
35.4%
Holding
2,914
New
228
Increased
1,572
Reduced
705
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 12.74%
2 Healthcare 7.53%
3 Financials 7.09%
4 Consumer Staples 6.81%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARR icon
2026
Par Pacific Holdings
PARR
$4.03B
$7K ﹤0.01%
457
+179
+64% +$3.04K
PDM
2027
Piedmont Realty Trust
PDM
$1.22B
$7K ﹤0.01%
708
+599
+550% +$7.52K
PRGS icon
2028
Progress Software
PRGS
$1.65B
$7K ﹤0.01%
168
+17
+11% +$786
RGP icon
2029
Resources Connection
RGP
$135M
$7K ﹤0.01%
396
+139
+54% +$2.79K
RRR icon
2030
Red Rock Resorts
RRR
$3.86B
$7K ﹤0.01%
218
RWT
2031
Redwood Trust
RWT
$585M
$7K ﹤0.01%
1,262
-16
-1% -$124
SEAT icon
2032
Vivid Seats
SEAT
$87.9M
$7K ﹤0.01%
47
SGMO
2033
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$7K ﹤0.01%
1,342
-2,550
-66% -$13.1K
SITM icon
2034
SiTime
SITM
$14.6B
$7K ﹤0.01%
95
+79
+494% +$10.2K
SLVM icon
2035
Sylvamo
SLVM
$1.55B
$7K ﹤0.01%
205
+29
+16% +$1.1K
SPT icon
2036
Sprout Social
SPT
$527M
$7K ﹤0.01%
114
-123
-52% -$7.39K
TEVA icon
2037
Teva Pharmaceuticals
TEVA
$36.7B
$7K ﹤0.01%
914
-151
-14% -$1.33K
TRIP icon
2038
TripAdvisor
TRIP
$1.72B
$7K ﹤0.01%
321
+151
+89% +$3.38K
TRS icon
2039
TriMas Corp
TRS
$1.44B
$7K ﹤0.01%
280
TRUE
2040
DELISTED
TrueCar
TRUE
$7K ﹤0.01%
+4,610
New +$10.5K
UGP icon
2041
Ultrapar
UGP
$6.75B
$7K ﹤0.01%
3,391
+1,891
+126% +$4.74K
VKTX icon
2042
Viking Therapeutics
VKTX
$3.88B
$7K ﹤0.01%
2,658
-389
-13% -$1.27K
VREX icon
2043
Varex Imaging
VREX
$472M
$7K ﹤0.01%
348
-15
-4% -$328
VTLE
2044
DELISTED
Vital Energy
VTLE
$7K ﹤0.01%
119
+78
+190% +$5.55K
XSLV icon
2045
Invesco S&P SmallCap Low Volatility ETF
XSLV
$251M
$7K ﹤0.01%
178
CNSL
2046
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$7K ﹤0.01%
1,621
-31
-2% -$192
AEL
2047
DELISTED
American Equity Investment Life Holding Company
AEL
$7K ﹤0.01%
199
+54
+37% +$2.03K
RETA
2048
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7K ﹤0.01%
285
-5,600
-95% -$155K
UNVR
2049
DELISTED
Univar Solutions Inc.
UNVR
$7K ﹤0.01%
318
-54
-15% -$1.36K
TMX
2050
DELISTED
Terminix Global Holdings, Inc.
TMX
$7K ﹤0.01%
186
+126
+210% +$5.39K

Similar funds

Quadrant Capital Group's Q3 2022 Portfolio in Review

As of Q3 2022, Quadrant Capital Group held 2,914 positions worth $756M, up 1.6% from $744M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Quadrant Capital Group deployed $56.9M of net new capital in Q3 2022, opening 228 new positions and adding to 1,572 existing holdings. Its largest new stake was iShares US Technology ETF: 3,200 shares worth $235K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Schwab Fundamental US Large Company Index ETF, an estimated $14M trimmed.

  • Quadrant Capital Group's largest Q3 2022 buy was iShares US Technology ETF: 3,200 shares worth $235K.
  • Quadrant Capital Group added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $17.3M increase.
  • Quadrant Capital Group's biggest Q3 2022 reduction was Schwab Fundamental US Large Company Index ETF, cutting an estimated $14M.
  • Quadrant Capital Group fully exited China Life Insurance Company Ltd. in Q3 2022, selling an estimated $146K.
  • Quadrant Capital Group's ten largest holdings make up 35% of its $756M portfolio in Q3 2022.
  • Quadrant Capital Group opened 228 new positions and closed 170 in Q3 2022.
  • Quadrant Capital Group's portfolio value rose 1.6% quarter-over-quarter to $756M.

Based on Quadrant Capital Group's 13F filing for Q3 2022, filed 10 Nov 2022.